CSHL AR 1977.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

CSHL AR 1977.Pdf ANNUAL REPORT 1977 COLD SPRING HARBOR, NEW YORK COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR, LONG ISLAND, NEW YORK OFFICERS OF THE CORPORATION Dr. Harry Eagle, Chairman Edward Pulling, Vice-Chairman Dr. Bayard Clarkson, Secretary Clarence E. Galston, Treasurer William R. Udry, Assistant Secretary-Treasurer Dr. James D. Watson, Laboratory Director William R. Udry, Administrative Director BOARD OF TRUSTEES Institutional Trustees State University of New York at Stony Brook Albert Einstein College of Medicine Dr. Joseph R. Kates Dr. Harry Eagle University of Wisconsin Columbia University Dr. Julian Davies Dr. Charles R. Cantor Wawepex Society Duke University Bache Bleecker Dr. Walter Guild Harvard University Individual Trustees School of Public Health Dr. Howard Hiatt Emilio G. Collado Long Island Biological Association Robert L. Cummings Norris Darrell Edward Pulling Walter N. Frank, Jr. Massachusetts Institute of Technology Clarence E. Galston Dr. Herman Eisen William R. Grant New York University Medical Center Mrs. Robert H. P. Olney Dr. Vittorio Defendi Walter H. Page William S. Robertson Princeton University Mrs. Franz Schneider Dr. Arnold J. Levine Dr. James D. Watson The Rockefeller University Dr. Rollin Hotchkiss Honorary trustees Sloan-Kettering Institute Dr. Alexander Hollaender Dr. Bayard Clarkson Dr. H. Bentley Glass Officers and trustees listed are as of December 31,1977. DIRECTOR'S REPORT When I was a boy in Chicago, the scientist was a poorlyabout that we are closet big businessmen who need to paid, absent-minded dreamer, very bright,if not abe kept in check by massive regulations, if not the threat genius, and culturally destined never to lead the masses, of jail. And all because the word has been spread that much less have anything to say to any public officialDNA, the stuff that makes up our genes, might do us all more important than a high school principal. Then in.I find this total nonsense and cannot think of any came Oppenheimer and the atomic bomb, and physi-potential environmental pollutant that worries me less. cists became men of affairs whom we and the GeneralsEveryone I know who now works with DNA feels the could not live without. Biologists were another matter.same, and mere mention of "NIH Guidelines" or No one thought they posed a threat to anyone; they"Memorandums of Understanding" makes our mouths would grow better hybrid corn or even someday curefroth. Under ordinary circumstances our response cancer, if they stayed by themselves and did not take onwould be obvious-head down to Washington and tell roles where they would only get in someone else's way. Congress that these scaremongers are an odd coalition I became one of them, and for twenty years it seemed Iof environmentalists wanting to block anything new and had entered the best of all possible worlds. Lots ofmiddle-class leftists who view the new genetics as a money was dug up by Mary Lasker and her crowd, withplausible tool for further "enslaving the masses." scarcely any accountability save for the quality of our The heart of our trouble, however, does not lie with science. Even better, no one got mad at us when wethe far-out doomsday scenarios these pathetic souls didn't soon hit lots of practical medical jackpots. And sopeddle. It was we presumably responsible molecular it went until Vietnam. Then came the teach-ins at whichbiologists who first gave the DNA scare its legitimacy. our students were told that the White House collectivelyTo be sure we never said we were deeply worried, for had the brains of a goose, a belief soon reinforced bynone of us were. I don't remember experiencing even Lyndon Johnson when he went out to NIH to give the five seconds of mild anxiety prior to signing the call for a word that we troublemakers had better start being usefulmoratorium. This document, a semiofficial response to or the gravy train would end. fears of genetic engineering at the service of CIA types, Being a brand-new Salk, however, is not that easy. It isurged restraints on the making of certain recombinant not that we do not want to be do-gooders, but if it was agenomes until we convened a gathering of international cinch to come up with a new vitamin that would makebigwigs at Asilomar on the Monterey Peninsula. There everyone live to 100 years of age without Social Securitywe were to discuss whether the 1973 breakthrough that it would have happened long ago. Invariably, greatgave us recombinant DNA was likely to generate challenges mean we don't know what to do next. Con- dangerous new bugs. I didn't know how we could solve sequently, most of our research efforts are holding oper-this dilemma but saw no harm in calling for a little ations which, given time, hopefully will generate unex-scientific restraint in the then post-Watergate mood of pected observations. With further luck we may gain a self-confession. Most of us were liberal-left types from fresh outlook on some pressing human problem such as birth, and our fellow McGovernites would now see that too many mosquitos or god-awful arthritis. So whilewe were not always out for quick fame and could place generally we don't go to work thinking about what wethe general good ahead of our immediate scientific can do next for our fellowman, we never lost any sleep goals. worrying about whether we were in cahoots with the Here we were terribly naive-the real world never idle rich who preach the virtues of hard work to othersstops anything it wants unless it has already smelled and then live off more pollution. Far better to be thoughtsmoke. Though everyone at Asilomar kept saying "po- unworldly and of conscience clean. tential risk," experienced newspaper addicts thought Now, however, we are in a strange mess. The word is differently. No one would invent phrases like P3 or EK2 5 unless they could measure the monster's size. The very cannot be dishonest. This is a point about which Con- act of setting up committees to pinpoint the "most risky" gress needs no education, and once the issue was raised experiments could only magnify the public fear that we on Capitol Hill it became very likely that some form of biologists now had our own diabolical form of the punitive legislation would be enacted to ensure strict bomb. compliance with the guidelines. By this stage I knew we were in way over our heads If, instead, the recombinant DNA community had been divided as to whether we needed any guidelines, and felt that this senseless hysteria should somehow be the final outcome would have been less clear and might nipped in the bud. So I argued, to the surprise of most at have been decided by whether the Senate and the Asilomar, against the forming of any official guidelines House had the gumption for still another regulatory that spelled out how we should work with recombinant commission. But with virtually every first-class molecu- DNA. I thought any regulations by necessity had to be lar geneticist then arguing that we needed protection capricious, and in the absence of even the slightest reason for being afraid, we were very silly to be making from ourselves. Congress would have been accused of shirking its duty if it did not seize the initiative. It then all this fuss. O nly Joshua Lederberg and Stanley Cohen were publicly on my side, and those who privately became a question of how to get a law where we, not the agreed with me thought I was risking my hide by appear- professional demonstrators, would control the action. ing so indifferent to the general good. Almost everyone Up through today the final outcome is still unclear, reasoned that the publ ic would not dump the matter and and that three years have passed since Asilomar without so went along with Sidney Brenn^s.eloquent plea thal legislation reflects more the inherent chaos of Congress we must make a show of seff: restraint or the lawyers and than the skill with which we lobby. Though there have ethicists would take over and give us stupid laws that been moments of panic, the situation is now less out of could really shut us down. control. The most chilling early proposal from Senator Kennedy's bailiwick was that final power should reside Unfortunately, the high hopes of many that A|ijbmar in a committee so constituted by law that scientists who might defuse the public concern, were soon dashed. know what D N A is must be in the minority. The vision of Within weeks Congress got into the act, and the guys a "Friend of the Earth" bearing a large wig righteously who gave us the guidelines soon found Themselves in telling us what not to do could be a scene from MASH. front of Senator Kennedy. Given the importance as- And Representative Rogers' Health Subcommittee dal- cribed to the topic, ,he saw no reason to accept the lied briefly with the thought that the way to keep us argument that a matter which, might affect the life or ,day fines־a־B e a n was the taint of a felony and $50,000 death of our society should be left jp. the scientists' penalties which most certainly would make docile pup- hands. Just the opposite— it seemed the perfect occa- pets even of our nation's bankers, much less our scieti- sion for the public to be Risked whether they were to be tists. the next guinea pigs for our experiments. Here the Through these ups and downs we occasionally h^ve molecular biologists quickly found they had little room had the hope that recombinant DN A would finally so to maneuver.
Recommended publications
  • Radiation Medicine Program
    Radiation Medicine Program ANNUAL 2020 REPORT 2021 VALUES MISSION Innovation Advance exemplary radiation Excellence medicine through patient Collaboration care, research & education Accountability in partnership with CONTENTS Integrity our patients & community 4 A Message from the Chief 6 Program Overview 7 2020: The Year in Numbers 8 Strategic Roadmap to 2026 VISION 10 Clinical Care CURE EVOLVE 15 Quality & Safety Predictive Health & Precision Radiation Medicine. Advanced Particle Adaptive Radiotherapy Therapy & Theranostics 18 Education Personalized Care. 21 Research Global Impact. 26 Team RMP COMFORT & CONNECT Systems to Maximize CONFIDENCE Innovation & Wellbeing Technology-enabled Patient Experience Transformation A MESSAGE FROM THE CHIEF The Radiation Medicine Program (RMP) at the Princess Margaret Cancer Centre is committed to delivering the highest standard of patient care. Over the RMP’s innovative education programs continue to thrive and attract a diverse group of national and international attendees. Our award-winning Accelerated past year, our dynamic multidisciplinary team of radiation oncologists, medical physicists, radiation therapists, administrators, and support staff have worked Education Program (AEP) demonstrated extraordinary resourcefulness this past year, standing strong amidst the pandemic, and continuing to provide top- together to advance our vision of “Precision Radiation Medicine. Personalized Care. Global Impact.” RMP continues to uphold our foundational values of level education to a broad spectrum of learners.
    [Show full text]
  • Stem Cell Strategy by Establishing the Till & Mcculloch Medicines of Tomorrow Innovation Fund
    A Pre-Budget Submission to the House of Commons Standing Committee on Finance To Implement the Canadian Stem Cell Strategy By Establishing The Till & McCulloch Medicines of Tomorrow Innovation Fund James Price President & CEO Canadian Stem Cell Foundation February 9, 2016 EXECUTIVE SUMMARY Stem cells represent the biggest innovation in medicine of the last half century. These cells have the power to cure many diseases for which current medical practice can only provide symptomatic relief and chronic care – a reality that is straining health care systems in Canada and in countries around the globe. Stem cells are a hallmark of Canadian innovation. They were first discovered in Canada and Canada is one of the top three countries in stem cell R&D, with our scientists ranking among the best in the world. Recent investments, such as the Government’s $20-million commitment to establish a cell-manufacturing facility in Toronto and the $114-million Medicine By Design grant for the University of Toronto, will help Canada move forward. However, major commitments by competitor jurisdictions – most notably California, with its investment of $3 billion, and Japan, with an investment of $1 billion in stem cells and regenerative medicine -- challenge Canada’s leadership in this sector of the knowledge economy. Moreover, Canada lacks a national plan to succeed in the coming cell therapy and regenerative medicine boom. The Canadian Stem Cell Strategy -- created in consultation with 150 scientists, medical doctors, leaders from major health charities, industry experts, investors and philanthropists – will: • deliver up to 10 new curative therapies within 10 years; • transform health care and ease the strain on the health system; and • attract private investment and generate 12,000 jobs for Canadians.
    [Show full text]
  • By the Numbers Excellence, Innovation, Leadership: Research at the University of Toronto a Powerful Partnership
    BY THE NUMBERS EXCELLENCE, INNOVATION, LEADERSHIP: RESEARCH AT THE UNIVERSITY OF TORONTO A POWERFUL PARTNERSHIP The combination of U of T and the 10 partner hospitals affiliated with the university creates one of the world’s largest and most innovative health research forces. More than 1,900 researchers and over 4,000 graduate students and postdoctoral fellows pursue the next vital steps in every area of health research imaginable. UNIVERSITY OF TORONTO Sunnybrook Health St. Michaelʼs Sciences Centre Hospital Womenʼs College Bloorview Kids Hospital Rehab A POWERFUL PARTNERSHIP Baycrest Mount Sinai Hospital The Hospital University Health for Sick Children Network* Centre for Toronto Addiction and Rehabilitation Mental Health Institute *Composed of Toronto General, Toronto Western and Princess Margaret Hospitals 1 UNIVERSITY OF TORONTO FACULTY EXCELLENCE U of T researchers consistently win more prestigious awards than any other Canadian university. See the end of this booklet for a detailed list of awards and honours received by our faculty in the last three years. Faculty Honours (1980-2009) University of Toronto compared to awards held at other Canadian universities International American Academy of Arts & Sciences* Gairdner International Award Guggenheim Fellows National Academies** Royal Society Fellows Sloan Research Fellows American Association for the Advancement of Science* ISI Highly-Cited Researchers*** 0 20 40 60 801 00 Percentage National Steacie Prize Molson Prize Federal Granting Councilsʼ Highest Awards**** Killam Prize Steacie
    [Show full text]
  • Printable List of Laureates
    Laureates of the Canadian Medical Hall of Fame A E Maude Abbott MD* (1994) Connie J. Eaves PhD (2019) Albert Aguayo MD(2011) John Evans MD* (2000) Oswald Avery MD (2004) F B Ray Farquharson MD* (1998) Elizabeth Bagshaw MD* (2007) Hon. Sylvia Fedoruk MA* (2009) Sir Frederick Banting MD* (1994) William Feindel MD PhD* (2003) Henry Barnett MD* (1995) B. Brett Finlay PhD (2018) Murray Barr MD* (1998) C. Miller Fisher MD* (1998) Charles Beer PhD* (1997) James FitzGerald MD PhD* (2004) Bernard Belleau PhD* (2000) Claude Fortier MD* (1998) Philip B. Berger MD (2018) Terry Fox* (2012) Michel G. Bergeron MD (2017) Armand Frappier MD* (2012) Alan Bernstein PhD (2015) Clarke Fraser MD PhD* (2012) Charles H. Best MD PhD* (1994) Henry Friesen MD (2001) Norman Bethune MD* (1998) John Bienenstock MD (2011) G Wilfred G. Bigelow MD* (1997) William Gallie MD* (2001) Michael Bliss PhD* (2016) Jacques Genest MD* (1994) Roberta Bondar MD PhD (1998) Gustave Gingras MD* (1998) John Bradley MD* (2001) Phil Gold MD PhD (2010) Henri Breault MD* (1997) Richard G. Goldbloom MD (2017) G. Malcolm Brown PhD* (2000) Jean Gray MD (2020) John Symonds Lyon Browne MD PhD* (1994) Wilfred Grenfell MD* (1997) Alan Burton PhD* (2010) Gordon Guyatt MD (2016) C H G. Brock Chisholm MD (2019) Vladimir Hachinski MD (2018) Harvey Max Chochnov, MD PhD (2020) Antoine Hakim MD PhD (2013) Bruce Chown MD* (1995) Justice Emmett Hall* (2017) Michel Chrétien MD (2017) Judith G. Hall MD (2015) William A. Cochrane MD* (2010) Michael R. Hayden MD PhD (2017) May Cohen MD (2016) Donald O.
    [Show full text]
  • The American Association of Immunologists Oral History Project
    The American Association of Immunologists Oral History Project Transcript Matthew D. Scharff, M.D. May 9, 2015 New Orleans, LA Interview conducted by Brien R. Williams, Ph.D. Transcription: TechniType Transcripts Transcript copy editors: John S. Emrich, Ph.D., and Charles L. Richter, M.A. Final edit by: John S. Emrich, Ph.D. © 2016 The American Association of Immunologists, Inc. Publicly released transcripts of The American Association of Immunologists, Inc. (AAI) Oral History Project are freely available for non-commercial use according to the Fair Use provisions of the United States Copyright Code and International Copyright Law. Advance written permission is required for reproduction, redistribution, and extensive quotation or excerpting. Permission requests should be made to: The American Association of Immunologists, 1451 Rockville Pike, Suite 650, Rockville, MD 20852. To cite an interview, please use the following general format: [Name of interviewee], interview by [name of interviewer], [date], The American Association of Immunologists Oral History Project. http://www.aai.org/OHP (accessed [date]). Williams: This is an interview with Dr. Matthew D. Scharff for the American Association of Immunologists Oral History Project. Dr. Scharff is Distinguished Professor at the Albert Einstein College of Medicine. He was awarded the inaugural AAI Award for Excellence in Mentoring in 1998, and the AAI-BioLegend Herzenberg Award right now [2015]. We are at the IMMUNOLOGY 2015™ annual meeting in New Orleans, Louisiana. Today is Saturday, May 9th, and I’m Brien Williams. So, Dr. Scharff, thank you very much for doing this today, and I’d like to ask you, go back as far as you can in your family background.
    [Show full text]
  • STEMCELLNETWORK.CA the Mission of the Stem Cell
    STEM CELL NETWORK SUMMER 2006 VOLUME 5, NUMBER 1 FATHERS OF THE FIELD How two quiet Canadians changed the course of history in biological research. CRITICAL MASS AHEAD OF THE CURVE A CANADIAN A pioneering past and a culture of Finding the way inside the ‘black box’ COMES HOME collaboration combine to make Toronto of cancer, Dr. John Dick has changed One of America’s leading researchers a world leader in stem cell science. our understanding of how to fight takes up a new challenge in the city the deadly disease. where he began his brilliant career. WWW.STEMCELLNETWORK.CA The mission of the Stem Cell Network is to be a catalyst for realizing the full potential of stem cell research for Canadians. STEM CELL NETWORK Frank Gleeson, Chair, Board of Directors Dr. Michael Rudnicki, Scientific Director Dr. Janet Rossant, Deputy Scientific Director Drew Lyall, Executive Director Cathy Campbell, SCN Communications Lori Barron, SCN Communications Joe Sornberger, Writer CONTACT US AT: 451 Smyth Road, Ottawa, ON K1H 8M5 Tel: (613)562.5696 Fax: (613)562.5631 Website: www.stemcellnetwork.ca Publication Mail Agreement Number 40664504 The contents of this publication may be reprinted or used in radio or television without permission. However, a credit is requested. In print, please send a copy to the Stem Cell Network. STEM CELL NETWORK TABLE OF CONTENTS Welcome to Toronto - Dr. Michael Rudnicki .......................................1 Critical Mass .................................................................................2 The Fathers of the Field .................................................................8 A Canadian comes home - Interview with Dr. Gordon Keller ...............14 The world’s best feel right at home ..............................................15 On the Cover: Ahead of the curve - Interview with Dr.
    [Show full text]
  • More Than Microscopes: the DIFFERENCE CANADIANS MAKE SAVING LIVES THROUGH MEDICAL RESEARCH
    More Than Microscopes: THE DIFFERENCE CANADIANS MAKE SAVING LIVES THROUGH MEDICAL RESEARCH healthpartners.ca 150 YEARS … 150 MEDICAL RESEARCH ADVANCES … $150 MILLION RAISED: Canadian Researchers Make a Mark Here — and Around the World Rick Perciante, Chair, Eileen Dooley Board of Directors CEO, HealthPartners HealthPartners Pablum to improve infant nutrition. The ability of Without a breakthrough using stem cell-based T-cells to destroy bacteria and viruses and marshal therapy to treat aggressive forms of relapsing- the immune system. The Cobalt-60 ‘bomb’ to remitting multiple sclerosis, Jennifer Molson kill cancer cells. Controlled gene mutation. The wouldn’t have been able to participate in a link between stress and disease. Insulin to treat bone marrow transplant trial, which essentially diabetes. Child-resistant medical containers. transformed her life. Without ground-breaking Discovery of stem cells. drug therapies, eight-year-old Kaiden Ames would probably not be alive today, and his Despite an overall population of fewer than parents wouldn’t have the chance to see him 40 million, Canada has nurtured a striking number grow up and even be a parent himself. Without of scientists and researchers whose breakthrough deep brain stimulation surgery, Herb Durand medical discoveries — and their ongoing wouldn’t be able to fulfill a long-time dream: to contributions to medical knowledge — have hold his grandchild. And without the tremendous improved, or have the potential to improve, the strides that have been made in diabetes research, health of millions of people around the world, not Dwayne Vermette certainly wouldn’t be living a just across our vast country. healthy lifestyle after being diagnosed with type 2 diabetes in his 30s — including having the ability HealthPartners is proud to play a leadership role to manage his condition with pills rather than a in connecting donor dollars to life-enhancing and daily injection of insulin.
    [Show full text]
  • 2006-2007 Annual Report
    2007 annual report 1 April 06 - 31 March 07 the future is in our genes. Chairman’s Message 02 President’s Message 04 OGI’s Mission 06 Research Programs Genetic Basis of Human Health 08 Biomarkers 12 Infectious Diseases and Promoting Global Health 14 Biodiversity, the Environment and Looking Ahead 16 Research Programs 18 Business Development Investments 20 Science - Industry Workshops 22 Outreach Public Outreach and Next Generation Innovators 24 Reaching Out Through The Arts 26 Workshops and Talks 28 Operations Board of Directors and Staff 29 Financial Snapshot 30 Financial Statements (inserted into flap at back) Copyright 2007 Ontario Genomics Institute 2007 annual report • 01 Chairman’s Message As Chair of the Ontario Genomics Institute (OGI), I am teomics research and to the growing cadre of internation- proud to report that the past year was for OGI a very posi- ally-recognized scientific researchers in this province whose tive reflection of our goal of augmenting -- through our knowledge and technical prowess are driving leading-edge focus on the genomics sector -- Ontario’s role as a pre- genomics research that will, in the long run, benefit all eminent centre in the life sciences industry. Now entering Canadians and help sustain and improve us economically. its seventh year, OGI continues to realize the benefits of sound strategic thinking, a clear direction, broad and fruit- Other partnerships have also been crucial. As always, the ful strategic partnerships, excellent recruitment and the partnerships with the various universities, research hospitals strong support of its major stakeholders. and other life science research institutions in Ontario (and beyond) has been of paramount importance.
    [Show full text]
  • Report 1978 Cold Spring Harbor Laboratory
    COLDLABORATORY SPRING HARBOR ANNUAL REPORT 1978 COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR, NEW YORK Cover: Participants at 1978 Symposium (top to bottom) G. Selzer, F. Stahl, and J. Strathern; A. Kornberg, A. Falaschi, and R. Holliday; W. Arber and D. Nathans; W. Udry, A. Bukhari, and D. Baltimore Picture credits: Cover, 82, 90, 140, Ross Meurer; 14, Cindy Carpenter; 19, W. Udry; 11, 12,13, 17, 20, 67, 136, 142, 143, 153, Robert Yaffe COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR, LONG ISLAND, NEW YORK OFFICERS OF THE CORPORATION Dr. Harry Eagle, Chairman Edward Pulling, Vice-Chairman Dr. Bayard Clarkson, Secretary Clarence E. Galston, Treasurer Robert L. Cummings, Assistant Treasurer William R. Udry, Administrative Director BOARD OF TRUSTEES Institutional Trustees Albert Einstein College of Medicine University of Wisconsin Dr. Harry Julian Davies Columbia University Wawepex Society Dr. Charles R. Cantor Bache Bleecker Duke University Dr. Walter Guild Individual Trustees Long Island Biological Association Emilio G. Collado Edward Pulling Robert L. Cummings Massachusetts Institute of Technology Roderick H. Cushman Dr. Herman Eisen Norris Darrell Memorial Sloan-Kettering Cancer Center Walter N. Frank, Jr. Dr. Bayard Clarkson Clarence E. Galston Mary Lindsay New York University Medical Center William S. Robertson Dr. Vittorio Defendi Mrs. Franz Schneider Princeton University Alexander C. Tomlinson Dr. Arnold J. Levine Dr. James D. Watson The Rockefeller University Dr. Rollin Hotchkiss Honorary trustees State University of New York Dr. H. Bentley Glass at Stony Brook Dr. Alexander Hollaender Dr. Joseph R. Kates Officers and trustees listed are as of December 31, 1978 DIRECTOR'S REPORT The collective decisions of knowledgeable men go sourone likes to advertise that we may have no meaningful more often than we want.
    [Show full text]
  • 167Th University of Notre Dame Commencement and Mass Program University of Notre Dame
    Notre Dame Law School NDLScholarship Commencement Programs Law School History 5-18-2012 167th University of Notre Dame Commencement and Mass Program University of Notre Dame Follow this and additional works at: http://scholarship.law.nd.edu/commencement_programs Part of the Law Commons Recommended Citation University of Notre Dame, "167th University of Notre Dame Commencement and Mass Program" (2012). Commencement Programs. Paper 5. http://scholarship.law.nd.edu/commencement_programs/5 This Program is brought to you for free and open access by the Law School History at NDLScholarship. It has been accepted for inclusion in Commencement Programs by an authorized administrator of NDLScholarship. For more information, please contact [email protected]. th MAY 18-20, 2012 167UNIVERSITY OF NOTRE DAME COMMENCEMENT 1 SCHEDULE OF EVENTS 2–4 p.m. THURSDAY, MAY 17 PROGRAM OF LIBERAL STUDIES GRADUATION RECEPTION 9 p.m. South Dining Hall – Oak Room SENIOR CLASS PRAYER SERVICE AND LAST VISIT TO 3–5 p.m. THE BASILICA AND GROTTO DEPARTMENT OF CLASSICS AND PROGRAM Senior only event OF ARABIC LANGUAGE AND CULTURE SENIOR Basilica of the Sacred Heart – Grotto of Our Lady of Lourdes RECOGNITION CEREMONY AND RECEPTION North Dining Hall – F-Wing FRIDAY, MAY 18 3–5 p.m. EDUCATION, SCHOOLING, AND SOCIETY RECEPTION 9:30–11:30 a.m. Graduates and their families are invited MINOR IN EUROPEAN STUDIES RECOGNITION LaFortune Student Center – Notre Dame Room BREAKFAST Hosted by the Nanovic Institute for European Studies 3–5 p.m. For reservations, please contact the Institute DEPARTMENT OF PHILOSOPHY RECEPTION AND RECOGNITION CEREMONY Morris Inn Decio Faculty Hall – First Floor 11 a.m.–1 p.m.
    [Show full text]
  • James E. Till Fonds B2005-0031 B2010-0028
    University of Toronto Archives and Records Management Services James E. Till fonds B2005-0031 B2010-0028 Harold Averill, July 2006 Revised by Garron Wells, January 2011 Emily Sommers, April 2021 © University of Toronto Archives and Records Management Services, 2021 James E. Till fonds University of Toronto Archives B2005-0031, B2010-0028 Contents Biographical note ..................................................................................................................... 3 Scope and content ................................................................................................................... 5 Series 1: Personal ...................................................................................................................... 6 Series 2: Correspondence ....................................................................................................... 7 Series 3: University of Toronto .................................................................................................. 8 Series 4: National Cancer Institute of Canada, Ontario Cancer Institute ....................... 10 Series 5: Professional organizations ...................................................................................... 12 Series 6: Research ................................................................................................................... 13 Series 7: Manuscripts and publications ............................................................................... 14 Series 8: Addresses ................................................................................................................
    [Show full text]
  • Oral History Center University of California the Bancroft Library Berkeley, California
    Oral History Center, The Bancroft Library, University of California Berkeley Oral History Center University of California The Bancroft Library Berkeley, California J. Michael Bishop Scientist, UCSF Chancellor, and Nobel Laureate Interviews conducted by Sally Smith Hughes in 2016 and 2017 Copyright © 2017 by The Regents of the University of California Oral History Center, The Bancroft Library, University of California Berkeley ii Since 1954 the Oral History Center of the Bancroft Library, formerly the Regional Oral History Office, has been interviewing leading participants in or well-placed witnesses to major events in the development of Northern California, the West, and the nation. Oral History is a method of collecting historical information through tape-recorded interviews between a narrator with firsthand knowledge of historically significant events and a well-informed interviewer, with the goal of preserving substantive additions to the historical record. The tape recording is transcribed, lightly edited for continuity and clarity, and reviewed by the interviewee. The corrected manuscript is bound with photographs and illustrative materials and placed in The Bancroft Library at the University of California, Berkeley, and in other research collections for scholarly use. Because it is primary material, oral history is not intended to present the final, verified, or complete narrative of events. It is a spoken account, offered by the interviewee in response to questioning, and as such it is reflective, partisan, deeply involved, and irreplaceable. ********************************* All uses of this manuscript are covered by a legal agreement between The Regents of the University of California and J. Michael Bishop dated June 22, 2017. The manuscript is thereby made available for research purposes.
    [Show full text]